AVITA Medical (RCEL) EPS (Weighted Average and Diluted) (2018 - 2025)
Historic EPS (Weighted Average and Diluted) for AVITA Medical (RCEL) over the last 8 years, with Q3 2025 value amounting to -$0.46.
- AVITA Medical's EPS (Weighted Average and Diluted) rose 2580.65% to -$0.46 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.99, marking a year-over-year increase of 1076.23%. This contributed to the annual value of -$1.4 for FY2023, which is 23084.11% down from last year.
- Per AVITA Medical's latest filing, its EPS (Weighted Average and Diluted) stood at -$0.46 for Q3 2025, which was up 2580.65% from -$0.38 recorded in Q2 2025.
- In the past 5 years, AVITA Medical's EPS (Weighted Average and Diluted) ranged from a high of $0.38 in Q1 2022 and a low of -$0.73 during Q1 2024
- Its 5-year average for EPS (Weighted Average and Diluted) is -$0.2, with a median of -$0.34 in 2023.
- Per our database at Business Quant, AVITA Medical's EPS (Weighted Average and Diluted) surged by 22014.79% in 2022 and then plummeted by 26400.0% in 2023.
- Quarter analysis of 5 years shows AVITA Medical's EPS (Weighted Average and Diluted) stood at $0.24 in 2021, then dropped by 8.33% to $0.22 in 2022, then crashed by 227.27% to -$0.28 in 2023, then crashed by 121.43% to -$0.62 in 2024, then rose by 25.81% to -$0.46 in 2025.
- Its last three reported values are -$0.46 in Q3 2025, -$0.38 for Q2 2025, and -$0.53 during Q1 2025.